CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 116 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,036 | -25.0% | 17,082 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $29,381 | +13.9% | 17,082 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $25,794 | -5.6% | 17,082 | 0.0% | 0.01% | -11.1% |
| Q4 2022 | $27,331 | +9.3% | 17,082 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $25,000 | -19.4% | 17,082 | 0.0% | 0.01% | -10.0% |
| Q2 2022 | $31,000 | -32.6% | 17,082 | 0.0% | 0.01% | -23.1% |
| Q1 2022 | $46,000 | -37.8% | 17,082 | 0.0% | 0.01% | -38.1% |
| Q4 2021 | $74,000 | -14.9% | 17,082 | 0.0% | 0.02% | -22.2% |
| Q3 2021 | $87,000 | -34.1% | 17,082 | 0.0% | 0.03% | -42.6% |
| Q1 2021 | $132,000 | +17.9% | 17,082 | 0.0% | 0.05% | +6.8% |
| Q4 2020 | $112,000 | – | 17,082 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |